论文部分内容阅读
以预胶化淀粉为赋型剂,制备阿昔洛韦胶囊,其体外溶出(T80=10.88min)明显快于市售片剂(T80=15.52min);其人体相对生物利用度的药-时曲线下面积AUC=3.7978±0.2640μg·h/ml及峰浓度Cmax=0.589±0.029μg/ml,显著高于市售片剂,其AUC=1.7708±0.1419μg·h/ml;Cmax=0.480±0.023μg/m
The acyclovir capsules were prepared with pregelatinized starch as excipient, which was significantly faster than the commercial tablets (T80 = 15.52 min) in vitro (T80 = 10.88 min). The relative bioavailability of the drug - The area under the curve AUC = 3.7978 ± 0.2640 μg · h / ml and the peak concentration Cmax = 0.589 ± 0.029 μg / ml, significantly higher than the commercial tablets, with AUC = 1.7708 ± 0. 1419 μg · h / ml; Cmax = 0.480 ± 0.023 μg / m